Skip to main content
CWAN
CWAN logo

CWAN · Clearwater Analytics Holdings, Inc.

Track CWAN — free
Market Cap
$7.33B
Shares
298.49M
All earnings calls

Earnings call · FY2024 Q1

Clearwater Analytics Holdings, Inc. Q1 FY2024 Earnings Call

Clearwater Analytics Holdings, Inc. Q1 FY2024 Earnings Call

Concluded May 1, 2024 Audio replay
May 1, 2024 1:00:16 56 turns
Period
FY2024 Q1
Runtime
1:00:16
Sources
4 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Geographic Expansion 20 Product Platform Wins (Jump, Prism) 20 Alternative Assets / LPX 18 Cross-Sell / Multi-Product Strategy 16 New Logo Wins Across Industries 14 Client Mix (Asset Managers vs Insurance) 13

Management tone

Confident

Net tone +78 · low hedging

Grounding quotes
  • “Q1 2024 delivered on all those goals”
  • “gross revenue retention grew from an already outstanding 98% to an incredible 99%”
  • “We feel really good that the new leadership we announced last quarter is already adding value”
  • “we also worried about people drawing a straight line. So it's not, there's no reason to be cautious”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $102.72M +21.4% YoY
Diluted EPS $0.01
Gross margin 72.6% +1.9 pp YoY
Net income $1.90M

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Revenue
full year 2024
$438M – $442M
Adjusted EBITDA
full year 2024
$137M – $139M
Revenue
second quarter of 2024
$105M – $106M
Adjusted EBITDA
second quarter of 2024
$31M

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

United States$83.14M +18.7% YoY
Non Us$19.58M +34.6% YoY
Full-screen source Call document